Psychemedics Retained Earnings (Accumulated Deficit) 2010-2024 | PMD
Psychemedics retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Psychemedics Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024 |
$-19 |
| 2023 |
$-17 |
| 2022 |
$-12 |
| 2021 |
$-10 |
| 2020 |
$-9 |
| 2019 |
$-4 |
| 2018 |
$-1 |
| 2017 |
$-2 |
| 2016 |
$-5 |
| 2015 |
$-8 |
| 2014 |
$-7 |
| 2013 |
$-7 |
| 2012 |
$-7 |
| 2011 |
$-7 |
| 2010 |
$-8 |
| 2009 |
$-8 |
Psychemedics Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024-12-31 |
$-19 |
| 2024-09-30 |
$-19 |
| 2024-06-30 |
$-18 |
| 2024-03-31 |
$-17 |
| 2023-12-31 |
$-17 |
| 2023-09-30 |
$-16 |
| 2023-06-30 |
$-14 |
| 2023-03-31 |
$-13 |
| 2022-12-31 |
$-12 |
| 2022-09-30 |
$-11 |
| 2022-06-30 |
$-10 |
| 2022-03-31 |
$-10 |
| 2021-12-31 |
$-10 |
| 2021-09-30 |
$-8 |
| 2021-06-30 |
$-8 |
| 2021-03-31 |
$-9 |
| 2020-12-31 |
$-9 |
| 2020-09-30 |
$-8 |
| 2020-06-30 |
$-7 |
| 2020-03-31 |
$-5 |
| 2019-12-31 |
$-4 |
| 2019-09-30 |
$-2 |
| 2019-06-30 |
$-2 |
| 2019-03-31 |
$-2 |
| 2018-12-31 |
$-1 |
| 2018-09-30 |
$-1 |
| 2018-06-30 |
$-1 |
| 2018-03-31 |
$-2 |
| 2017-12-31 |
$-2 |
| 2017-09-30 |
$-4 |
| 2017-06-30 |
$-4 |
| 2017-03-31 |
$-4 |
| 2016-12-31 |
$-5 |
| 2016-09-30 |
$-6 |
| 2016-06-30 |
$-8 |
| 2016-03-31 |
$-9 |
| 2015-12-31 |
$-8 |
| 2015-09-30 |
$-8 |
| 2015-06-30 |
$-8 |
| 2015-03-31 |
$-7 |
| 2014-12-31 |
$-7 |
| 2014-09-30 |
$-6 |
| 2014-06-30 |
$-7 |
| 2014-03-31 |
$-7 |
| 2013-12-31 |
$-7 |
| 2013-09-30 |
$-7 |
| 2013-06-30 |
$-7 |
| 2013-03-31 |
$-7 |
| 2012-12-31 |
$-7 |
| 2012-09-30 |
$-7 |
| 2012-06-30 |
$-7 |
| 2012-03-31 |
$-7 |
| 2011-12-31 |
$-7 |
| 2011-09-30 |
$-7 |
| 2011-06-30 |
$-7 |
| 2011-03-31 |
$-8 |
| 2010-12-31 |
$-8 |
| 2010-09-30 |
$-8 |
| 2010-06-30 |
$-8 |
| 2010-03-31 |
$-8 |
| 2009-12-31 |
$-8 |
| 2009-09-30 |
$-8 |
| 2009-06-30 |
$-8 |
| 2009-03-31 |
$-7 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.000B |
$0.020B |
|
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
|
